The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
A Partial Structural and Functional Rescue of a Retinitis Pigmentosa Model with Compacted DNA Nanoparticles
Open accessAbstract
Previously we have shown that compacted DNA nanoparticles can drive high levels of transgene expression after subretinal injection in the mouse eye. Here we delivered compacted DNA nanoparticles containing a therapeutic gene to the retinas of a mouse model of retinitis pigmentosa. Nanoparticles containing the wild-type retinal degeneration slow (Rds) gene were injected into the subretinal space of rds(+/-) mice on postnatal day 5. Gene expression was sustained for up to four months at levels up to four times higher than in controls injected with saline or naked DNA. The nanoparticles were taken up into virtually all photoreceptors and mediated significant structural and biochemical rescue of the disease without histological or functional evidence of toxicity. Electroretinogram recordings showed that nanoparticle-mediated gene transfer restored cone function to a near-normal level in contrast to transfer of naked plasmid DNA. Rod function was also improved. These findings demonstrate that compacted DNA nanoparticles represent a viable option for development of gene-based interventions for ocular diseases and obviate major barriers commonly encountered with non-viral based therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Single-molecule DNA nanoparticles compacted by polyethylene glycol (PEG)-substituted lysine peptides (CK30-PEG) have been used to carry payloads up to 20 kb in size,82,83 with several groups demonstrating their safety in BALB/c mice and rds+/− Rho-/- or Abca4-/- mouse models of retinal degeneration.82–86”
From Gene Therapy for Retinal Degenerative Diseases: Progress, Challenges, and Future Directions (2023) · cites this paper as [82]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A new mathematical model for relative quantification in real-time RT-PCR
Pfaffl, M. W. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.9.e45 · Cited by 34,610
Safety and Efficacy of Gene Transfer for Leber's Congenital Amaurosis
Maguire, A. M., Simonelli, F., Pierce, E. A., Pugh, E. N., Mingozzi, F., Bennicelli, J., Banfi, S., Marshall, K. A., Testa, F., Surace, E. M., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802315 · Cited by 2,145
Effect of gene therapy on visual function in Leber’s congenital amaurosis
Bainbridge, J. W. B., Smith, A. J., Barker, S. S., Robbie, S., Henderson, R., Balaggan, K., Viswanathan, A., Holder, G. E., Stockman, A., Tyler, N., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802268 · Cited by 1,924
Gene therapy restores vision in a canine model of childhood blindness
Acland, G. M., Aguirre, G. D., Ray, J., Zhang, Q., Aleman, T. S., Cideciyan, A. V., Pearce-Kelling, S. E., Anand, V., Zeng, Y., Maguire, A. M., et al. (2001) · Nature Genetics · doi:10.1038/ng0501-92 · Cited by 1,202 · cited 1×
“Viral gene therapy has been remarkably successful in treating some types of ocular diseases, the most notable example of which to date being the AAV-mediated long-term rescue of vision in Briard dogs harboring a mutation in RPE65 [1,2].”
BackgroundElectroporation and RNA interference in the rodent retina in vivo and in vitro
Matsuda, T., & Cepko, C. L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2235688100 · Cited by 1,032
Cell fate determination in the vertebrate retina.
Cepko, C. L., Austin, C. P., Yang, X.-J., Alexiades, M. R., & Ezzeddine, D. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.2.589 · Cited by 989
Rods and cones in the mouse retina. I. Structural analysis using light and electron microscopy
Carter‐Dawson, L. D., & LaVail, M. M. (1979) · The Journal of Comparative Neurology · doi:10.1002/cne.901880204 · Cited by 695
Cideciyan, A. V., Alemán, T. S., Boye, S. L., Schwartz, S., Kaushal, S., Román, A. J., Pang, J., Sumaroka, A., Windsor, E. A. M., Wilson, J. M., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807027105 · Cited by 674
Apoptotic photoreceptor cell death in mouse models of retinitis pigmentosa.
Portera‐Cailliau, C., Sung, C.-H., Nathans, J., & Adler, R. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.3.974 · Cited by 628
Lagali, P. S., Bálya, D., Awatramani, G. B., Münch, T. A., Kim, D. S., Busskamp, V., Cepko, C. L., & Roska, B. (2008) · Nature Neuroscience · doi:10.1038/nn.2117 · Cited by 580
Research works printed but not linked: 1
- MJ Cooper, 2007, Nonviral gene transfer in the lung: from animal to human., Molecular therapy, S15, 315
Cited by
Sorted by citations
Nanotechnology in Ocular Drug Delivery
Patel, D. H., Pathak, D., & Giradkar, P. (2021) · Springer eBooks · doi:10.1007/978-981-33-4497-6_18 · Cited by 362
Nanoparticle diffusion in, and microrheology of, the bovine vitreous ex vivo
Xu, Q., Boylan, N. J., Suk, J. S., Wang, Y.-Y., Nance, E. A., Yang, J., McDonnell, P. J., Cone, R. A., Duh, E. J., & Hanes, J. S. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.01.018 · Cited by 339
Vector platforms for gene therapy of inherited retinopathies
Trapani, I., Puppo, A., & Auricchio, A. (2014) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2014.08.001 · Cited by 191
Punzo, C., Xiong, W., & Cepko, C. L. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.r111.304428 · Cited by 185
DNA nanoparticle-mediated ABCA4 delivery rescues Stargardt dystrophy in mice
Han, Z., Conley, S. M., Makkia, R. S., Cooper, M. J., & Naash, M. I. (2012) · Journal of Clinical Investigation · doi:10.1172/jci64833 · Cited by 150
Self-citationBramall, A. N., Wright, A. F., Jacobson, S. G., & McInnes, R. R. (2010) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-060909-153227 · Cited by 152
Gene Therapy for Retinal Degenerative Diseases: Progress, Challenges, and Future Directions
Drag, S., Dotiwala, F., & Upadhyay, A. K. (2023) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.64.7.39 · Cited by 145
Nanotechnology approaches for ocular drug delivery
Kannan, R. M., Xu, Q., & Kambhampati, S. P. (2013) · Middle East African Journal of Ophthalmology · doi:10.4103/0974-9233.106384 · Cited by 125
Seeing the light after 25 Years of retinal gene therapy
Trapani, I., & Auricchio, A. (2018) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2018.06.006 · Cited by 124
Clinical applications of retinal gene therapy
Lipinski, D. M., Thake, M., & MacLaren, R. E. (2012) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2012.09.001 · Cited by 123
Cai, X., Conley, S. M., Nash, Z. A., Fliesler, S. J., Cooper, M. J., & Naash, M. I. (2009) · The FASEB Journal · doi:10.1096/fj.09-139147 · Cited by 123
Self-citationTaking Stock of Retinal Gene Therapy: Looking Back and Moving Forward
Bennett, J. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2017.03.008 · Cited by 117
Nanoparticle-based technologies for retinal gene therapy
Adijanto, J., & Naash, M. I. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2014.12.028 · Cited by 107
Self-citationNanoparticles for retinal gene therapy
Conley, S. M., & Naash, M. I. (2010) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2010.04.004 · Cited by 106
Self-citationNano-ophthalmology: Applications and considerations
Kamaleddin, M. A. (2017) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2017.02.007 · Cited by 105
Nanotechnology in ophthalmology
Zarbin, M. A., Montemagno, C. D., Leary, J. F., & Ritch, R. H. (2010) · Canadian Journal of Ophthalmology · doi:10.3129/i10-090 · Cited by 97
Cai, X., Sezate, S. A., Seal, S., & McGinnis, J. F. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.08.030 · Cited by 91
Self-citationComparative Analysis of DNA Nanoparticles and AAVs for Ocular Gene Delivery
Han, Z., Conley, S. M., Makkia, R. S., Guo, J., Cooper, M. J., & Naash, M. I. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052189 · Cited by 87
Self-citationNanomedicine in Ophthalmology: The New Frontier
Zarbin, M. A., Montemagno, C. D., Leary, J. F., & Ritch, R. H. (2010) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2010.03.019 · Cited by 86
Toxicity of nanomaterials to the eye
Prow, T. W. (2009) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.65 · Cited by 77
Koirala, A., Makkia, R. S., Conley, S. M., Cooper, M. J., & Naash, M. I. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt013 · Cited by 75
Self-citationOcular Delivery of Compacted DNA-Nanoparticles Does Not Elicit Toxicity in the Mouse Retina
Ding, X., Quiambao, A. B., Fitzgerald, J. B., Cooper, M. J., Conley, S. M., & Naash, M. I. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007410 · Cited by 71
Self-citationA review of therapeutic prospects of non-viral gene therapy in the retinal pigment epithelium
Koirala, A., Conley, S. M., & Naash, M. I. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.06.002 · Cited by 74
Self-citationGene Therapy in Inherited Retinal Diseases: An Update on Current State of the Art
Amato, A., Arrigo, A., Aragona, E., Manitto, M. P., Saladino, A., Bandello, F. M., & Parodi, M. B. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.750586 · Cited by 68
Nanotechnology and Nanotoxicology in Retinopathy
Jo, D. H., Lee, T. G., & Kim, J. H. (2011) · International Journal of Molecular Sciences · doi:10.3390/ijms12118288 · Cited by 66
Touchard, E., Berdugo, M., Bigey, P., El Sanharawi, M., Savoldelli, M., Naud, M.-C., Jeanny, J.-C., & Behar-Cohen, F. (2012) · Molecular Therapy · doi:10.1038/mt.2011.304 · Cited by 63
Read, S. P., Cashman, S. M., & Kumar‐Singh, R. (2010) · Molecular Therapy · doi:10.1038/mt.2010.167 · Cited by 62
Nanocarriers of nanotechnology in retinal diseases
Al-Halafi, A. M. (2014) · Saudi Journal of Ophthalmology · doi:10.1016/j.sjopt.2014.02.009 · Cited by 57
Synthesis and Characterization of Glycol Chitosan DNA Nanoparticles for Retinal Gene Delivery
Mitra, R. N., Han, Z., Merwin, M. J., Taai, M. A., Conley, S. M., & Naash, M. I. (2013) · ChemMedChem · doi:10.1002/cmdc.201300371 · Cited by 59
Self-citationGene therapy in animal models of autosomal dominant retinitis pigmentosa.
Rossmiller, B. P., Mao, H., & Lewin, A. S. (2012) · PubMed · Cited by 52
The potential of nanomedicine therapies to treat neovascular disease in the retina
Farjo, K. M., & Ma, J. (2010) · Vascular Cell · doi:10.1186/2040-2384-2-21 · Cited by 53
Oligomerization of Prph2 and Rom1 is essential for photoreceptor outer segment formation
Zulliger, R., Conley, S. M., Mwoyosvi, M. L., Al‐Ubaidi, M. R., & Naash, M. I. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy240 · Cited by 51
Self-citationNon-viral therapeutic approaches to ocular diseases: An overview and future directions
Zulliger, R., Conley, S. M., & Naash, M. I. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.10.007 · Cited by 50
Self-citationGene Therapy for PRPH2-Associated Ocular Disease: Challenges and ProspectsPreprint
Conley, S. M., & Naash, M. I. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a017376 · Cited by 50
Self-citationNanoparticle-mediated gene transfer specific to retinal pigment epithelial cells
Koirala, A., Makkia, R. S., Cooper, M. J., & Naash, M. I. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.08.062 · Cited by 49
Self-citationKoirala, A., Conley, S. M., Makkia, R., Liu, Z., Cooper, M. J., Sparrow, J. R., & Naash, M. I. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.08.299 · Cited by 47
Self-citationChakraborty, D., Conley, S. M., Stuck, M. W., & Naash, M. I. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq410 · Cited by 47
Self-citationNanomedicine for the treatment of retinal and optic nerve diseases
Zarbin, M. A., Montemagno, C. D., Leary, J. F., & Ritch, R. H. (2012) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2012.10.003 · Cited by 49
Nanoparticle-mediated miR200-b delivery for the treatment of diabetic retinopathy
Mitra, R. N., Nichols, C. A., Guo, J., Makkia, R. S., Cooper, M. J., Naash, M. I., & Han, Z. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.06.020 · Cited by 47
Self-citationGene Therapy of Inherited Retinal Degenerations: Prospects and Challenges
Trapani, I., Banfi, S., Simonelli, F., Surace, E. M., & Auricchio, A. (2015) · Human Gene Therapy · doi:10.1089/hum.2015.030 · Cited by 46
McGill, T. J., Prusky, G. T., Douglas, R. M., Yasumura, D., Matthes, M. T., Lowe, R. J., Duncan, J. L., Yang, H., Ahern, K., Daniello, K. M., et al. (2012) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.12-9569 · Cited by 45
PEG–PLA microparticles for encapsulation and delivery of Tat-EGFP to retinal cells
Rafat, M., Cléroux, C. A., Fong, W. G., Baker, A. N., Leonard, B. C., O’Connor, M. D., & Tsilfidis, C. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.01.031 · Cited by 44
The Y141C knockin mutation in RDS leads to complex phenotypes in the mouse
Stuck, M. W., Conley, S. M., & Naash, M. I. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu345 · Cited by 42
Self-citationPolymeric Vectors for Ocular Gene Delivery
Tamboli, V., Mishra, G. P., & Mitra, A. K. (2011) · Therapeutic Delivery · doi:10.4155/tde.11.20 · Cited by 42
Advances in ophthalmic optogenetics: approaches and applications
Prosseda, P. P., Tran, M., Kowal, T., Wang, B., & Sun, Y. (2022) · Biomolecules · doi:10.3390/biom12020269 · Cited by 41
Pharmaceutical microscale and nanoscale approaches for efficient treatment of ocular diseases
Bravo‐Osuna, I., Andrés‐Guerrero, V., Abal, P. P., Molina-Martínez, I. T., & Herrero‐Vanrell, R. (2016) · Drug Delivery and Translational Research · doi:10.1007/s13346-016-0336-5 · Cited by 42
Gene Therapy of ABCA4-Associated DiseasesPreprint
Auricchio, A., Trapani, I., & Allikmets, R. L. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a017301 · Cited by 42
Han, Z., Conley, S. M., & Naash, M. I. (2011) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.10-6916 · Cited by 40
Self-citationNon‐viral retinal gene therapy: a review
Issa, P. C., & MacLaren, R. E. (2011) · Clinical and Experimental Ophthalmology · doi:10.1111/j.1442-9071.2011.02649.x · Cited by 40
Nano and microtechnologies for ophthalmic administration, an overview
Herrero‐Vanrell, R., Vicario‐de‐la‐Torre, M., Andrés‐Guerrero, V., Barbosa-Alfaro, D., Molina-Martínez, I. T., & Bravo‐Osuna, I. (2013) · Journal of Drug Delivery Science and Technology · doi:10.1016/s1773-2247(13)50016-5 · Cited by 39
Prph2 initiates outer segment morphogenesis but maturation requires Prph2/Rom1 oligomerization
Conley, S. M., Stuck, M. W., Watson, J. N., Zulliger, R., Burnett, J. L., & Naash, M. I. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy359 · Cited by 39
Self-citationDNA nanoparticles are safe and nontoxic in non-human primate eyes
Kelley, R. A., Conley, S. M., Makkia, R. S., Watson, J. N., Han, Z., Cooper, M. J., & Naash, M. I. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s157000 · Cited by 37
Self-citationNovel molecular mechanisms for Prph2‐associated pattern dystrophy
Chakraborty, D., Strayve, D., Makia, M. S., Conley, S. M., Kakakhel, M., Al‐Ubaidi, M. R., & Naash, M. I. (2019) · The FASEB Journal · doi:10.1096/fj.201901888r · Cited by 31
Self-citationResearch Models and Gene Augmentation Therapy for CRB1 Retinal Dystrophies
Boon, N., Wijnholds, J., & Pellissier, L. P. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00860 · Cited by 32
Daich Varela, M., Georgiadis, A., & Michaelides, M. (2023) · British Journal of Ophthalmology · doi:10.1136/bjo-2022-321903 · Cited by 30
The utility and risks of therapeutic nanotechnology in the retina
Scheive, M., Yazdani, S., & Hajrasouliha, A. R. (2021) · Therapeutic Advances in Ophthalmology · doi:10.1177/25158414211003381 · Cited by 28
Recent Developments in Gene Therapy for Neovascular Age-Related Macular Degeneration: A Review
Finocchio, L., Zeppieri, M., Gabai, A., Toneatto, G., Spadea, L., & Salati, C. (2023) · Biomedicines · doi:10.3390/biomedicines11123221 · Cited by 31
Investigation of nanoparticles using magnetic resonance imaging after intravitreal injection
Raju, H. B., Hu, Y., Padgett, K. R., Rodriguez, J. E., & Goldberg, J. L. (2011) · Clinical and Experimental Ophthalmology · doi:10.1111/j.1442-9071.2011.02651.x · Cited by 28
Regenerative nanomedicine and the treatment of degenerative retinal diseases
Zarbin, M. A., Montemagno, C. D., Leary, J. F., & Ritch, R. H. (2011) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.167 · Cited by 28
The K153Del PRPH2 mutation differentially impacts photoreceptor structure and function
Chakraborty, D., Conley, S. M., Zulliger, R., & Naash, M. I. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw193 · Cited by 28
Self-citationPotential therapeutic strategies for photoreceptor degeneration: the path to restore vision
Karamali, F., Behtaj, S., Abraki, S. B., Hadady, H., Atefi, A., Savoj, S., Soroushzadeh, S., Najafian, S., Nasr‐Esfahani, M. H., & Klassen, H. J. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03738-4 · Cited by 27
Non-toxic retention of nanoceria in murine eyes.
Cai, X., Seal, S., & McGinnis, J. F. (2016) · PubMed Central · Cited by 26
Self-citationRegenerative Nanomedicine for Vision Restoration
Zarbin, M. A., Arlow, T., & Ritch, R. H. (2013) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2013.05.025 · Cited by 25
Kansara, V. S., Cooper, M. J., Sesenoglu‐Laird, O., Muya, L. W., Moen, R. C., & Ciulla, T. A. (2020) · Translational Vision Science & Technology · doi:10.1167/tvst.9.13.21 · Cited by 24
Self-citationDNA Nanoparticles: Detection of Long-Term Transgene Activity in Brain using Bioluminescence Imaging
Yurek, D. M., Fletcher, A. M., McShane, M., Kowalczyk, T. H., Padegimas, L., Weatherspoon, M. R., Kaytor, M. D., Cooper, M. J., & Ziady, A. G. (2011) · Molecular Imaging · doi:10.2310/7290.2010.00053 · Cited by 24
Self-citationBarnea-Cramer, A. O., Singh, M. S., Fischer, D., Silva, S. R. D., McClements, M. E., Barnard, A. R., & MacLaren, R. E. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.01.023 · Cited by 24
Stuck, M. W., Conley, S. M., & Naash, M. I. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.683698 · Cited by 23
Self-citationGene Therapy to the Retina and the Cochlea
Crane, R., Conley, S. M., Al‐Ubaidi, M. R., & Naash, M. I. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.652215 · Cited by 24
Self-citationThe Interplay between Peripherin 2 Complex Formation and Degenerative Retinal Diseases
Tebbe, L., Kakakhel, M., Makia, M. S., Al‐Ubaidi, M. R., & Naash, M. I. (2020) · Cells · doi:10.3390/cells9030784 · Cited by 22
Self-citationThe Future of Nanomaterials Tackling the Challenge of Delivering Nucleic Acids to the Retina
Hurst, J., Adams, F., & Schnichels, S. (2024) · Advanced Functional Materials · doi:10.1002/adfm.202407173 · Cited by 21
PROGRESS TOWARD THE MAINTENANCE AND REPAIR OF DEGENERATING RETINAL CIRCUITRY
Vugler, A. (2010) · Retina · doi:10.1097/iae.0b013e3181e2a680 · Cited by 21
CRISPR genome engineering for retinal diseases
Kantor, A., McClements, M. E., Peddle, C. F., Fry, L. E., Salman, A., Cehajic‐Kapetanovic, J., Xue, K., & MacLaren, R. E. (2021) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2021.01.024 · Cited by 19
Rim formation is not a prerequisite for distribution of cone photoreceptor outer segment proteins
Conley, S. M., Al‐Ubaidi, M. R., Han, Z., & Naash, M. I. (2014) · The FASEB Journal · doi:10.1096/fj.14-251397 · Cited by 18
Self-citationNanoparticle‐motivated gene delivery for ophthalmic application
Mitra, R. N., Zheng, M., & Han, Z. (2015) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1356 · Cited by 18
Tebbe, L., Mwoyosvi, M. L., Crane, R., Makia, M. S., Kakakhel, M., Cosgrove, D. E., Al-Ubaidi, M. R., & Naash, M. I. (2023) · Nature Communications · doi:10.1038/s41467-023-36431-1 · Cited by 16
Self-citationBennett, J., Chung, D. C., & Maguire, A. M. (2012) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/b978-0-12-386509-0.00013-2 · Cited by 17
ROM1 contributes to phenotypic heterogeneity in PRPH2-associated retinal disease
Strayve, D., Makia, M. S., Kakakhel, M., Sakthivel, H., Conley, S. M., Al‐Ubaidi, M. R., & Naash, M. I. (2020) · Human Molecular Genetics · doi:10.1093/hmg/ddaa160 · Cited by 13
Self-citationRPE based gene and cell therapy for inherited retinal diseases: A review
Sanie‐Jahromi, F., & Nowroozzadeh, M. H. (2022) · Experimental Eye Research · doi:10.1016/j.exer.2022.108961 · Cited by 13
Shining light on CRISPR/Cas9 therapeutics for inherited retinal diseases
Geiger, A., Kennedy, J. G., Staker, L. G., Wensel, T. G., Casson, R. J., & Thomas, P. Q. (2025) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2025.101376 · Cited by 11
Non-Viral Delivery Systems to Transport Nucleic Acids for Inherited Retinal Disorders
Jony, M. J. H., Joshi, A., Dash, A. K., & Shukla, S. (2025) · Pharmaceuticals · doi:10.3390/ph18010087 · Cited by 10
Nanotherapy for Neural Retinal Regeneration
Yu, C., Dong, L., Lv, Y., Shi, X., Zhang, R., Zhou, W., Wu, H., Li, H., Li, Y., Zhou, L., et al. (2025) · Advanced Science · doi:10.1002/advs.202409854 · Cited by 10
Yurek, D. M., Hasselrot, U., Cass, W. A., Sesenoglu‐Laird, O., Padegimas, L., & Cooper, M. J. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.10.026 · Cited by 10
Self-citationNanoengineered biomaterials for retinal repair
Patel, B. B., Sharma, A. D., Mammadova, N., Sandquist, E. J., Uz, M., Mallapragada, S. K., & Sakaguchi, D. S. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813355-2.00010-7 · Cited by 8
Effective intravitreal gene delivery to retinal pigment epithelium with hyaluronic acid nanospheres
Crane, R., Makia, M. S., Zeibak, S., Tebbe, L., Ikelle, L., Woods, C. R., Conley, S. M., Acharya, G. S., Naash, M. I., & Al‐Ubaidi, M. R. (2024) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2024.102222 · Cited by 9
Self-citationDong, Y., Cai, X., Wu, Y., Liu, Y., Deng, L., & Chen, H. (2017) · PubMed · Cited by 8
Self-citationQi, X., Walton, D. A., Plafker, K. S., Boulton, M. E., & Plafker, S. M. (2022) · PubMed Central · Cited by 7
Non-viral gene therapy for Leber’s congenital amaurosis: progress and possibilities
Abdulsalam, L., Mordecai, J., & Ahmad, I. (2024) · Nanomedicine · doi:10.1080/17435889.2024.2443387 · Cited by 7
Emerging biotechnological strategies for non-viral antiangiogenic gene therapy
Liu, C., & Zhang, N. (2012) · Angiogenesis · doi:10.1007/s10456-012-9295-8 · Cited by 6
Zarbin, M. A., Leary, J. F., Montemagno, C. D., Ritch, R. H., & Humayun, M. S. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4557-0737-9.00036-9 · Cited by 6
A 350 bp region of the proximal promoter of Rds drives cell-type specific gene expression
Cai, X., Conley, S. M., Cheng, T., Al‐Ubaidi, M. R., & Naash, M. I. (2010) · Experimental Eye Research · doi:10.1016/j.exer.2010.04.017 · Cited by 6
Self-citationNanotechnology in Ophthalmology
Petrovic, N. T., Petrovic, M. J., Srećković, S., Jovanović, S., Todorović, D., & Vulovic, T. S. (2017) · Springer eBooks · doi:10.1007/978-3-319-56979-6_11 · Cited by 5
Cattaneo, A. G., Gornati, R., Bernardini, G., Sabbioni, E., Manzo, L., & Gioacchino, M. D. (2014) · Wiley eBooks · doi:10.1002/9781118856017.ch13 · Cited by 5
Nardella, M., Pellegrini, M., Yu, A. C., Adamo, G., Mura, M., & Busin, M. (2025) · Biomolecules · doi:10.3390/biom15111592 · Cited by 4
RDS Functional Domains and Dysfunction in Disease
Stuck, M. W., Conley, S. M., & Naash, M. I. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-17121-0_29 · Cited by 4
Self-citationOptogenetics: A Novel Therapeutic Avenue for Age-Related Macular Degeneration
Grenga, P., Ciancimino, C., Meduri, A., & Fragiotta, S. (2025) · Biomolecules · doi:10.3390/biom15091286 · Cited by 3
da Costa, B. L., Helms, K. M., Theodore, K., Tsai, Y., Caruso, S. M., Liu, S. J., de Carvalho, J. R. L., Nolan, N. D., Tahir, S., Makinson, C. D., et al. (2025) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2025.102740 · Cited by 3
Nonviral gene therapy for age-related macular degeneration
Thumann, G. (2011) · Expert Review of Ophthalmology · doi:10.1586/eop.10.83 · Cited by 2
Gene Therapy for Retinal Disease
Bennett, J., & Maguire, A. M. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4557-0737-9.00034-5 · Cited by 2
Cerium Oxide Nanoparticle Reduction of Oxidative Damage in Retina
Cai, X., Seal, S., & McGinnis, J. F. (2012) · Humana Press eBooks · doi:10.1007/978-1-61779-606-7_19 · Cited by 2
Self-citationPrazeres, D. M. F. (2011) · Wiley eBooks · doi:10.1002/9780470939918.ch6 · Cited by 2
Metadata
- Authors
- Cai, X., Nash, Z., Conley, S. M., Fliesler, S. J., Cooper, M. J., & Naash, M. I.
- Affiliations
- University of Oklahoma Health Sciences Center (US)
- Saint Louis University (US)
- Copernicus Therapeutics (United States) (US)
- Corresponding author
- Naash, Muna I.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2009-04-24
- Volume
- 4
- Issue
- 4
- Pages
- e5290
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC2669177
- OpenAlex
- W1969461625
- Cited by
- 109
- References
- 49
- Citations by year
- 2026: 2 · 2025: 8 · 2024: 3 · 2023: 3 · 2022: 5 · 2021: 5 · 2020: 5 · 2019: 1 · 2018: 7 · 2017: 4 · 2016: 4 · 2015: 7 · 2014: 8 · 2013: 8 · 2012: 14
- FWCI
- 5.24
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Foundation Fighting Blindness
- Research to Prevent Blindness
- Oklahoma Center for the Advancement of Science and Technology
- National Institutes of Health (EY018656)
- National Eye Institute (R56EY010609, EY007361, EY10609, R01EY007361, R01EY018656, R01EY010609, EY018656)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Keywords
- retinitis pigmentosa, gene therapy, subretinal injection, photoreceptors, cone function, rod function, electroretinogram, non-viral gene delivery, ocular gene therapy, mouse model
- MeSH terms
- Animals, Disease Models, Animal, DNA, Electroretinography, Immunohistochemistry, Intermediate Filament Proteins, Membrane Glycoproteins, Mice, Transgenic, Nerve Tissue Proteins, Retinitis Pigmentosa, Transgenes, Photoreceptor Cells, Vertebrate, Mice, Nanoparticles, Peripherins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review